Frontlight ResearchEarly access
Trial site
Międzyleski Szpital Specjalistyczny w Warszawie
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- IgA nephropathy2 trials
- Chronic kidney disease1 trial
- Crohn's disease1 trial
- Heart failure1 trial
- Neuromyelitis optica (NMOSD)1 trial
- Stroke1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 36 trials
- Status
- Completed3 trials
- Recruiting3 trials
- Lead sponsor
- Eli Lilly and Company1 trial
- Hoffmann-La Roche1 trial
- Novartis Pharmaceuticals1 trial
- Pharmacosmos A/S1 trial
- Shire1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- IgA nephropathy1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026